XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Jun. 30, 2023
Sep. 30, 2022
Current assets    
Cash and equivalents $ 9,957 $ 1,804
Receivables, less allowances of $100 and $100, respectively 2,491 2,261
Inventories 2,085 1,742
Other current assets 1,227 1,301
Current assets held-for-sale 0 1,398
Total current assets 15,760 8,506
Property, plant and equipment, net 2,268 2,239
Other assets    
Goodwill 14,131 13,946
Other intangible assets 6,147 6,572
Copeland note receivable and equity investment 3,359 0
Other 2,508 2,151
Noncurrent assets held-for-sale 0 2,258
Total other assets 26,145 24,927
Total assets 44,173 35,672
Current liabilities    
Short-term borrowings and current maturities of long-term debt 667 2,115
Accounts payable 1,218 1,276
Accrued expenses 4,729 3,038
Current liabilities held-for-sale 0 1,348
Total current liabilities 6,614 7,777
Long-term debt 7,642 8,259
Other Liabilities, Noncurrent 3,504 3,153
Noncurrent liabilities held-for-sale 0 167
Equity    
Common stock, $0.50 par value; authorized, 1,200.0 shares; issued, 953.4 shares; outstanding, 591.4 shares and 571.5 shares, respectively 477 477
Additional paid-in-capital 112 57
Retained earnings 39,624 28,053
Accumulated other comprehensive income (loss) (1,072) (1,485)
Cost of common stock in treasury, 381.9 shares and 362.0 shares, respectively (18,677) (16,738)
Common stockholders’ equity 20,464 10,364
Noncontrolling interests in subsidiaries 5,949 5,952
Total equity 26,413 16,316
Total liabilities and equity $ 44,173 $ 35,672
Treasury Stock, Common, Shares 381.9 362.0